Condition guide

Ehlers-Danlos syndrome pain

Ehlers-Danlos syndrome is a heritable connective tissue disorder. The loose joints and fragile tissue are written into your genes, and no amount of positive thinking changes that. Research also keeps finding a second layer to EDS pain: a nervous system that, after years of instability and injury, learns to amplify. Knowing about both layers opens up more options.

Reviewed by The Karuna Labs clinical teamUpdated

Why does Ehlers-Danlos syndrome cause chronic pain?

Ehlers-Danlos syndromes are heritable connective tissue disorders, so the tissue difference is genetic and real. Pain is near-universal: about 90% of adults with EDS report chronic pain. Unstable joints, repeated minor injuries, and muscle guarding start it. Research shows that central sensitization, a pain system stuck on high alert, often amplifies it, which is why pain frequently outgrows what scans and joint exams explain.

That second, nervous-system layer is a treatable one. It can be addressed alongside joint protection and strengthening, never instead of them.

At a glance

Definition
A group of heritable connective tissue disorders featuring joint hypermobility, stretchy or fragile skin, and tissue fragility
ICD-10
Q79.60–Q79.69 (hypermobile EDS is Q79.62); M35.7 is often used for hypermobility spectrum disorder
Classification
The 2017 international classification recognizes 13 subtypes, each with distinct features and genetics
Most common subtype
Hypermobile EDS (hEDS), the one subtype with no identified gene, so it is diagnosed clinically
How common pain is
About 90% of adults reported chronic pain in a Dutch EDS patient survey (n=273); reviews cite similar figures
Frequent companions
POTS and orthostatic intolerance, fatigue, anxiety, and gut symptoms travel with hEDS far more often than chance
Key mechanism
Joint instability and microtrauma start the pain; central sensitization often amplifies it
Related reading
Central sensitization, explained

Key takeaways

  • EDS pain is rooted in a real, genetic tissue difference. It is not imagined, not exaggerated, and not something brain retraining can cure. Anyone who implies otherwise has misunderstood the condition.
  • Even so, studies find the pain burden in hypermobile EDS often exceeds what joint exams and imaging can account for. That is the signature of a sensitized pain system amplifying real signals.
  • Fear of movement is understandable when joints dislocate. Left unchecked it feeds a loop of guarding, deconditioning, more instability and more pain, which makes everything worse.
  • The core of treatment is physical therapy done the EDS way: joint-aware, low-load, progressive strengthening. Pain-system-directed approaches can help the amplification layer alongside it.
  • A small minority of EDS subtypes are dangerous. Know the vascular EDS red flags, and treat sudden severe chest or abdominal pain in known EDS as an emergency.

What are the Ehlers-Danlos syndromes, and what is HSD?

The Ehlers-Danlos syndromes (EDS) are a family of inherited disorders of connective tissue, the collagen-rich material that holds joints, skin, blood vessels, and organs together. When collagen or the proteins that assemble it are built differently, tissue becomes more extensible and more fragile. Joints move beyond their normal range, skin may stretch or scar unusually, and ligaments sprain and strain easily.

The 2017 international classification (the field's current standard) recognizes 13 subtypes, most of them rare and each tied to specific genes. By far the most common is hypermobile EDS (hEDS), which is also the exception. No causative gene has been confirmed for it, so it is diagnosed clinically against a checklist of joint, skin, and systemic criteria.

Hypermobility spectrum disorder (HSD) was defined in the same 2017 framework for people who have symptomatic joint hypermobility (pain, instability, fatigue) but do not meet the full hEDS checklist. The label is different. The pain, and its management, are essentially the same. Nothing on this page depends on which side of that diagnostic line you fall on.

One distinction genuinely matters: hEDS and HSD are painful and life-altering but not life-threatening, while a few rare subtypes, vascular EDS above all, carry serious risks that need specialist surveillance. The red-flags section below covers the warning signs.

Why is chronic pain so common in EDS?

Pain in EDS is close to universal. In a survey of 273 members of the Dutch EDS patient organization, about 90% reported pain, most of it chronic, and 87% reported functional impairment from it. A 2017 review of pain management in EDS reached the same conclusion: chronic pain is one of the condition's defining burdens, and it is routinely undertreated.

The mechanical reasons stack on top of each other:

  • Joint instability. Lax ligaments let joints slide partly out of position (subluxation) or fully dislocate. Each event strains tissue, and the surrounding muscles are left doing a stabilizing job ligaments were supposed to do.
  • Repeated microtrauma. Everyday movement in a hypermobile joint produces small cumulative injuries. Sprains, strains, and overuse irritation never quite get a chance to settle.
  • Muscle guarding and spasm. Muscles clamp down to protect unstable joints. Chronically over-worked muscle becomes its own pain source, from neck and jaw to hips and back.
  • Impaired proprioception. Position sense is measurably reduced in hypermobile joints, so movements are less precise, which invites more of the minor injuries above.
  • Deconditioning. When movement hurts and joints feel untrustworthy, activity drops. Muscles weaken, joints lose their main remaining support, and the same movements now cause more strain than before.

Those factors form a spiral rather than a straight line. Instability causes pain, pain causes guarding and avoidance, avoidance causes weakness, and weakness causes more instability. Much of good EDS care is about interrupting that spiral. There is also a second, less visible accomplice.

Where does the nervous system come in?

Years of subluxations, sprains, and guarding mean the pain system receives a near-continuous stream of danger signals. Pain systems adapt to what they process. With enough repetition they can become sensitized: alarm circuits fire at lower thresholds, amplify what they receive, and stay switched on after the triggering signal stops. This is central sensitization, one of the best-documented phenomena in modern pain science.

This has been measured in EDS. A 2016 study in the European Journal of Pain tested people with hypermobile-type EDS and found lowered pain thresholds, including at sites away from symptomatic joints, plus an exaggerated wind-up response to repeated stimuli. The authors concluded that central sensitization is a mechanism of their pain, likely triggered by years of persistent nociceptive input from unstable joints. Later work has found similar signs in adolescents with hEDS and HSD.

This explains something many people with EDS know and few clinicians say out loud: the pain is often bigger than the pictures. Scans can look unremarkable while pain is severe, widespread, and constant. A sensitized pain system produces exactly that mismatch, so it is no reason to doubt the pain. The same amplification shows up in fibromyalgia, which overlaps heavily with hEDS.

Be precise about what this does and does not mean. EDS itself is not [neuroplastic pain](/neuroplastic-pain). The connective tissue difference is genetic, structural, and permanent. What the research shows is that central amplification, a neuroplastic *layer*, commonly builds on top of the structural one. The tissue layer needs joint-aware physical care. The amplification layer is what pain-system-directed treatment can address.

How do fear of movement and guarding feed the pain cycle?

If your shoulder has dislocated while reaching for a shelf, wariness about reaching is a form of learning. The trouble is that the nervous system generalizes. Wariness about one movement spreads to whole categories of activity, the body braces earlier and harder, and life contracts around an expanding list of things that feel unsafe. Pain researchers call this fear-avoidance pattern kinesiophobia. EDS is close to a worst-case setup for it, because the fear starts from real events.

Avoided movement weakens muscle. Weaker muscle gives the joint less support, so instability and pain arrive after smaller and smaller provocations, which confirms the fear that started the loop. Guarding also keeps muscles in low-grade contraction that hurts in its own right, and a vigilant, threatened nervous system is precisely the state in which central sensitization deepens.

The way out is graded, confidence-building strengthening guided by someone who understands hypermobile joints. Real risk still counts, and some movements genuinely do need modifying with EDS. The aim is to expand what feels safe at a pace the nervous system can accept, so protection stays proportionate to actual risk instead of expanding past it. EDS physical therapy and modern chronic pain treatment share that logic.

What conditions travel with hypermobile EDS?

hEDS rarely arrives alone. Recognizing its companions matters because each one is addressable, and because unexplained symptom pile-ups are a big part of why people with EDS get dismissed as anxious or somatizing.

  • Dysautonomia and POTS. Problems with automatic regulation of heart rate and blood pressure are common in hEDS. The most visible is postural orthostatic tachycardia syndrome (POTS): a racing heart, lightheadedness, brain fog, and exhaustion on standing. A 2017 expert review describes orthostatic intolerance and POTS as frequent, treatable features of hEDS. If dizziness is a dominant symptom, our chronic dizziness guide covers how persistent dizziness becomes self-sustaining.
  • Anxiety. Decades of studies find anxiety disorders substantially more common in hypermobile people. The association is strong enough that researchers treat it as part of the phenotype, likely involving autonomic dysfunction and heightened interoception rather than character. Anxiety also turns up the gain on a sensitized pain system, so treating it is pain treatment too.
  • Fatigue and sleep problems. Profound fatigue is one of the most disabling hEDS symptoms, fed by unrefreshing sleep, pain, deconditioning, and dysautonomia.
  • Gut symptoms. Reflux, bloating, and IBS-like symptoms are common, consistent with connective tissue and autonomic involvement in the gut.

A pattern worth noticing: pain amplification, POTS, anxiety, fatigue, and gut dysregulation are all conditions of nervous-system regulation. None of that makes them imaginary. It does make the nervous system a rational shared treatment target alongside joint care.

Which symptoms need urgent attention?

Most EDS pain, however severe, is not dangerous. A short list of situations is different, and knowing them is part of living safely with a connective tissue disorder.

  • Features suggesting vascular EDS (vEDS): a family history of arterial rupture, aneurysm, dissection, or organ (bowel or uterine) rupture at a young age; easy, severe bruising out of proportion to injury; thin, translucent skin with visible veins; and characteristic facial features. vEDS is rare, estimated at roughly 1 in 50,000 to 1 in 200,000, but it requires genetic confirmation and specialist surveillance. If any of this fits you or your family, ask for a referral to a geneticist.
  • Sudden, severe chest, abdominal, or flank pain in anyone with known or suspected EDS is an emergency. Call 911. In vEDS it can signal an arterial or bowel rupture, and telling emergency staff about the diagnosis changes what they look for.
  • New neurological deficits such as numbness, weakness, loss of bladder or bowel control, a severe new headache, or trouble speaking or seeing need urgent evaluation, whatever the cause.
  • A dislocated joint you cannot reduce. A joint that is visibly out and stays out needs prompt medical care, not endurance.

None of the self-management approaches on this page apply to these situations. Red-flag symptoms need a clinician, first and without delay.

How is Ehlers-Danlos syndrome diagnosed?

Diagnosis starts with a clinical assessment, usually the Beighton score (a nine-point scale of joint hypermobility) plus a structured history of dislocations, skin features, pain, and family history. From there the paths diverge by subtype. The rarer subtypes, including classical and vascular EDS, can be confirmed by genetic testing, while hEDS is diagnosed clinically against the 2017 criteria, because its gene has not been found. People whose symptomatic hypermobility does not meet the full checklist are given the HSD label instead.

Getting there can take years. Hypermobility is common, the symptoms sprawl across specialties, and many clinicians had little EDS training. If hypermobility plus chronic pain describes you, it is reasonable to ask your doctor directly about assessment against the 2017 criteria, and to ask for a genetics referral if any rarer-subtype features are present, especially the vascular red flags above.

A diagnosis is good for two things. It ends the demoralizing search for an explanation that fits, and it changes management: joint-aware physical therapy, screening for POTS and other companions, and, for specific subtypes, surveillance that can be lifesaving. What it should never become is a reason to stop treating the pain. Genetics and diagnosis belong with your clinicians. The daily work of managing pain still has more options than most people are offered.

What actually helps EDS pain?

No treatment changes the collagen you were born with. What treatment can do, with evidence behind it, is stabilize the joints, break the deconditioning spiral, and turn down the amplification. The elements:

  • Physical therapy, done the EDS way. Exercise is the cornerstone of management, per the 2017 international consensus on physical therapy for hypermobility. It has to respect the tissue, though: joint protection, low-load and closed-chain work, an emphasis on stability, proprioception, and endurance rather than stretching (hypermobile joints need strength, not more range), progressed gradually. A therapist who knows hypermobility is worth seeking out. Programs that combine exercise with education and confidence-building show particular promise for pain and function.
  • Pacing. Swinging between overdoing on good days and collapse afterward keeps both tissue and nervous system in crisis mode. Steady, planned activity that you raise gradually outperforms boom-and-bust. Our guide to living with chronic pain covers pacing in depth.
  • Treating the companions. Managing POTS, sleep, and anxiety with your medical team is pain treatment by another route, because each one feeds the sensitized state.
  • Pain-system-directed approaches, as an adjunct. Because central sensitization contributes to hEDS pain, approaches that target pain processing have a rational role alongside, never instead of, strengthening and specialist care. That means pain neuroscience education, graded exposure to feared movement, and other brain-first strategies. They address the amplification layer, not the connective tissue, and honest providers say so plainly. How that kind of retraining works in general is described in our program overview.
  • Practical supports. Braces, taping, compression garments, and pain medication prescribed and reviewed by your own clinicians all have roles. Medication decisions belong in that conversation, not on a web page.

The realistic goal is a stronger, steadier body, a calmer pain system, and a life that stops shrinking. Zero pain is rarely on offer. People with EDS reach that first goal regularly, usually with a team rather than a single fix.

When should you see a doctor about hypermobility pain?

  • Emergency, now: sudden severe chest, abdominal, or flank pain with known or suspected EDS; a possible arterial event; new neurological deficits; a dislocation you cannot reduce.
  • Soon: joint pain with hypermobility that has lasted more than three months; recurrent subluxations or dislocations; suspected POTS symptoms (racing heart and lightheadedness on standing); or any vascular-EDS features in you or your family, in which case ask about a genetics referral.
  • Worth a conversation: if you have an EDS or HSD diagnosis but pain dominates your life, ask specifically about hypermobility-aware physical therapy, about whether central sensitization is contributing, and about what would address it.

Many people with EDS arrive at appointments braced to be disbelieved, often after years of being told their tests are normal or their symptoms are anxiety. The research is unambiguous that EDS pain is real, common, and mechanistically explicable. A good clinician treats the joints and the pain system both, and takes you seriously about each. If chronic pain is new territory for you, our chronic pain overview is a grounding place to start.

Frequently asked questions

Is Ehlers-Danlos syndrome pain neuroplastic?

Partly, and the distinction matters. EDS itself is a genetic connective tissue disorder, not neuroplastic pain: unstable joints and fragile tissue generate real nociceptive signals no mindset can switch off.

Quantitative sensory testing in hypermobile EDS does find lowered pain thresholds and amplified wind-up, which is the signature of central sensitization. So the most accurate statement is that EDS pain usually starts in the tissue and in many people the nervous system comes to amplify it. The structural layer needs physical care. The amplification layer is where pain-system-directed approaches can help.

Can brain retraining cure Ehlers-Danlos syndrome?

No. Nothing retrains collagen. EDS is a heritable disorder. Treat any program claiming to cure it, or implying your tissue problem is really a belief problem, with deep skepticism.

What pain-system-directed treatment can honestly offer is a smaller target: reducing the amplification that a sensitized nervous system adds on top of the structural pain, and unwinding fear-avoidance patterns that drive deconditioning. For many people that meaningfully shrinks the pain burden. It works as an adjunct to strengthening and specialist care, never a substitute.

Is being hypermobile the same as having EDS?

No. Plenty of people, children and young women especially, have flexible joints with no symptoms at all, and that needs no treatment. EDS is diagnosed when hypermobility comes with the required pattern of joint, skin, and systemic features from the 2017 criteria. Symptomatic hypermobility that falls short of the full checklist is classified as hypermobility spectrum disorder (HSD).

HSD is not a consolation-prize diagnosis: pain and instability can be just as severe as in hEDS, and management is essentially identical.

Is exercise safe with EDS?

Yes. With the right kind and the right guidance, exercise is the cornerstone of EDS management according to the international physical therapy consensus. The caveats are real: programs need to protect joints, favor stability and strengthening over stretching, and progress gradually.

The riskier long-term path is usually avoiding movement, because weakening muscles leave hypermobile joints with even less support. If exercise has repeatedly flared you, that is an argument for a hypermobility-aware physical therapist and a slower ramp, not for stopping.

What is the ICD-10 code for Ehlers-Danlos syndrome?

EDS codes to the Q79.6- family, expanded in October 2021 into specific subtypes: Q79.60 (unspecified), Q79.61 (classical), Q79.62 (hypermobile), Q79.63 (vascular), and Q79.69 (other). M35.7 (hypermobility syndrome) is commonly used for hypermobility spectrum disorder.

Coding is your clinician's call. This is here so the codes on your paperwork make sense.

Why do so many people with EDS feel dismissed by doctors?

Several reasons compound: hEDS has no confirmatory lab test, symptoms sprawl across a dozen specialties, standard imaging often looks normal even when pain is severe, and the anxiety that genuinely travels with hypermobility makes it easy to misfile the whole picture as psychological. Surveys consistently document years-long diagnostic delays.

The science is on your side: pain in EDS is nearly universal, measurable sensitization helps explain pain that outruns imaging, and none of it means the pain is imagined. A written symptom history, the 2017 criteria, and a clinician willing to engage with them go a long way.

Sources & research.

  1. Malfait et al., Am J Med Genet C, 2017. The 2017 international classification of the Ehlers-Danlos syndromes
  2. Chopra et al., Am J Med Genet C, 2017. Pain management in the Ehlers-Danlos syndromes
  3. Voermans et al., J Pain Symptom Manage, 2010. Pain in Ehlers-Danlos syndrome is common, severe, and associated with functional impairment
  4. Di Stefano et al., Eur J Pain, 2016. Central sensitization as the mechanism underlying pain in joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type
  5. Hakim et al., Am J Med Genet C, 2017. Cardiovascular autonomic dysfunction in Ehlers-Danlos syndrome, hypermobile type
  6. Engelbert et al., Am J Med Genet C, 2017. The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome/hypermobile Ehlers-Danlos syndrome
  7. Byers et al., Am J Med Genet C, 2017. Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome
  8. Bulbena et al., Am J Med Genet C, 2017. Psychiatric and psychological aspects in the Ehlers-Danlos syndromes

Related guides.

Free consultation

Ready to unlearn your pain?

Talk with our care team about your pain, your history, and whether KVET™ is right for you. Free, and from the comfort of home.

Free. No symptom or health details are collected on this form.